Results (3617)
EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its April 2024 meeting.
NewsHumanCOVID-19Medicines
The European Medicines Agency's (EMA) office is closed from 18:00 on Wednesday 8 May 2024 to 07:30 on Monday 13 May 2024. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600.
NewsCorporate
Today, the European Centre for Disease Prevention and Control (ECDC), the European Chemicals Agency (ECHA), the European Environment Agency (EEA), the European Food Safety Authority (EFSA), and the European Medicines Agency (EMA) published a joint framework for action to strengthen cooperation to support the implementation of the One Health agenda...
NewsHumanVeterinaryCorporate
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.
NewsVeterinaryMedicines
Updated vaccines will help maintain protection against disease as virus continues to evolve.
NewsHumanCOVID-19Vaccines
The European Medicines Agency's (EMA) office is closed from 18:00 on Tuesday 30 April 2024 to 07:30 on Thursday 2 May 2024. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600.
NewsCorporate
EMA and the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) have signed a working arrangement with the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea for the exchange of confidential information on medical and medicinal products.
NewsCorporate
EMA has published a number of recommendations to address vulnerabilities in the production and delivery of medicines included in the Union list of critical medicines and strengthen their supply chain.
NewsHumanMedicine shortages
Report on COVID-19 vaccine strain updates: global regulators agree on timing and data requirements
NewsHumanMedicinesVaccines
GLP-1 receptor agonists: available evidence not supporting link with suicidal and self-injurious thoughts and actions
NewsHumanMedicinesPharmacovigilanceReferrals